ISTH Congress Abstracts

Official abstracts site for the ISTH Congress

MENU 
  • Home
  • Congress Archive
    • ISTH 2022 Congress
    • ISTH 2021 Congress
    • ISTH 2020 Congress
  • Resources
  • Search

ISTH 2022 Congress

July 9-13, 2022. London, England, UK.

View by Title View by Number View Themes
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Abstract Number: OC 26.2

    A dose-escalation phase 1 clinical trial of autologous iPSC-derived platelets (iPLAT1)

    N. Sugimoto1, J. kanda2, S. Nakamura3, T. Kitano2, S. Shimizu1, A. Shigemasa1, H. Hirai2, M. Minami2, H. Tada2, D. Momose4, K. Koh4, M. Nogawa5, N. Watanabe6, M. Handa6, A. Sawaguchi7, M. Tanaka8, T. Hayashi8, Y. Tani8, A. Takaori-Kondo9, K. Eto3

  • Abstract Number: PB1239

    A Familial Case of MYH9 Gene Mutation Associated with Impaired Platelet Functionality and Structural Alterations

    S. Safiullina1, N. Evtugina1, I. Andrianova1, R. Khismatullin1, O. Kravtsova1, A. Khabirova1, C. Nagaswami2, A. Daminova1, A. Peshkova3, J. Weisel4, R. Litvinov5

  • Abstract Number: PO0012

    A frequency of anti-PF4/heparin antibodies and LA in patients with COVID-19

    T. KIM1, S. Namgoong2, M. Choi2, H. Kim3, S. Jang4

  • Abstract Number: OC 37.4

    A humanized mouse model to assess the therapeutic potential of IdeS in hemophilia A with inhibitors

    M. Bou Jaoudeh1, V. Daventure2, S. Delignat2, J. astermark3, H. Lévesque4, V. Proulle5, S. Lacroix-Desmazes6

  • Abstract Number: PB1113

    A method for measuring chromogenic factor VIII activity unbiased by the presence of the bispecific antibody Emicizumab

    A. Weber, M. Billwein, A. Engelmaier, C. Zlabinger, G. Schrenk

  • Abstract Number: OC 49.3

    A microfluidic model to study the initiation of venous thrombosis

    L. Mereweather1, J. van Batenburg-Sherwood1, J. Ahnström1, I. Salles-Crawley2, J. Crawley1

  • Abstract Number: PB0051

    A Multicenter Cohort Study of COVID-19 Associated Venous Thromboembolism in Admitted Patients Followed Longitudinally 3-Months After Discharge

    C. Drury1, C. Lai2, G. Misselbrook3, A. Al Zaki2, G. Bhangu4, M. Conroy5, L. Eadie4, D. Kumar6, C. Li5, D. Manhas5, N. Singh4, J. Yuan4, A. Lee2, T. Wan7

  • Abstract Number: OC 13.5

    A Multicenter Randomized Clinical Trial of Modulation of Host Thromboinflammatory Response in Hospitalized Patients with COVID-19: The DAWn-Antico study

    M. Engelen1, J. Wauters1, J. Gunst1, C. Wouters1, C. Vandenbriele1, S. Rex1, M. Thomeer2, T. Fivez2, D. Mesotten2, D. Ruttens2, L. Heytens3, P. Verhamme4, T. Vanassche5

  • Abstract Number: VPB0141

    A near real-time surveillance algorithm to identify in-hospital VITT cases

    S. Williams, S. Sivapalaratnam, S. Vohra, P. Johnstone, A. Pentony, C. Gutteridge

  • Abstract Number: PB0666

    A new FVIII chromogenic assay with bovine FX is sensitive enough for the diagnosis of severe haemophilia A.

    M. Jacquemin1, J. Toelen2, K. Peerlinck2, P. Verhamme3, C. Van Laer4

  • Abstract Number: OC 44.3

    A new mouse model of impaired fibrin α-chain crosslinking shows increased venous thrombembolism

    C. Duval1, T. Feller2, H. mcPherson1, R. Ariëns3

  • Abstract Number: PB0804

    A new type 1 von Willebrand Disease (VWD) characterized by increased clearance of von Willebrand Factor (VWF) due to the heterozygous p.P1127S mutation: clinical phenotype and pathogenic mechanisms.

    M. Tardugno1, M. Sacco1, R. De Cristofaro1, S. Lancellotti2, F. Bernardi3, M. Pinotti3, A. Branchini4, B. Giusti5, G. Castaman6

  • Abstract Number: OC 41.5

    A novel and unique mechanism of αIIbβ3 regulation in platelets

    C. Kusch1, D. Stegner2, D. Johnson3, M. Meub4, P. Nurden5, C. Gross6, D. Semeniak6, J. Schenk7, M. Bender8, T. Vögtle9, K. Heinze7, M. Sauer10, A. Nurden5, B. Nieswandt8

  • Abstract Number: PB0295

    A Novel Assay to Investigate Thrombogenesis in TTP Patients

    A. Constantinescu-Bercu1, R. de Groot1, C. Vendramin1, R. Sivera1, C. Capelli1, K. Vanhoorelbeke2, M. Scully3

  • Abstract Number: PB1186

    A novel chemiluminescent-based Thrombin Generation Assay for near-patient monitoring.

    L. van Engelshoven1, C. van de Ridder2, D. Steeghs1, M. van Geffen1, C. van 't Veer1, W. van Heerde1

  • Abstract Number: PB0711

    A novel homozygous KLKB1 missense variant causative of severe Prekallikrein deficiency.

    M. Mitchell1, R. Wheeler2, J. Cutler2, G. Ling3

  • Abstract Number: PB1001

    A Novel Human Factor VIIa Chimera with Increased Tissue Factor-Independent Hemostatic and Anti-Inflammatory Activities

    A. Fager1, M. Hoffman2, D. Monroe3

  • Abstract Number: VPB1116

    A novel material for the improvement of HIT detection

    L. Chen1, H. Nguyen2

  • Abstract Number: OC 10.3

    A novel model of RUNX1-haploinsufficient (RUNX1Lo): Human megakaryocytes infused into mice further characterizes this defect and identifies potential therapeutics

    K. Lee, H. Ahn, M. Poncz

  • Abstract Number: PB1111

    A novel prothrombin R533Q variant in patient with recurrent venous thrombosis

    C. Van Laer1, K. Freson2, R. Lavend'homme2, V. Muczynski3, K. Peerlinck4, C. Thys2, M. Jacquemin5

  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 94
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2023 John Wiley & Sons, Inc. All Rights Reserved.
Wiley